Abstract
High-risk human papillomaviruses (HR-HPV) are the necessary cause of cervical carcinomas. To determine whether HPR-HPV DNA detection in primary routine screening could represent a sensitive and reliable technique for the detection of high-grade squamous intraepithelial lesions (HGSIL), laboratory analysis using 2 cytologic techniques (conventional and liquid-based), HPV testing with Hybrid Capture II assay (HC-II), followed by colposcopic examination of women with abnormal cervical finding and/or persistent HR-HPV infection, was conducted in 7932 women who had routine cervical examination. The sensitivity of HPV testing for detecting a histologically proven HGSIL was 100%, higher than that of conventional (68.1%) and liquid-based (87.8%) cytology. The low specificities of 85.6% and 87.3% of HPV testing slightly increased to 88.4% and 90.1% if HPV testing was reserved for woman >30 years old. The quantitative approach provided by the HC-II assay for the assessment of the viral load was not reliable for predicting HGSIL in normal smears. HR-HPV testing could be proposed in primary screening in association with cytology. With conventional cytology it significantly improves the detection of HGSIL. With the use of the same cervical scrape for HPV testing and liquid-based cytology, HR-HPV testing would allow to select positive samples treated in a second time for cytology which gives a good specificity. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Adam E, Kaufman RH and Berkova Z (1998) Is human papillomavirus testing an effective triage method for detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia?. Am J Obstet Gynecol 178: 1235–1244
Bosch FX, Manos MM and Munoz N (1995) Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective. J Natl Cancer Inst 87: 796–802
Clavel C, Bory JP and Rihet S (1998a) Comparative analysis of the human papillomavirus detection by Hybrid Capture assay and routine cytology screening to detect high grade cervical lesions. Int J Cancer 75: 525–528
Clavel C, Masure M and Putaud I (1998b) Hybrid Capture II, a new sensitive test for human papillomavirus detection. Comparison with Hybrid Capture I and PCR results in cervical lesions. J Clin Pathol 51: 737–740
Clavel C, Masure M and Bory JP (1999) Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women. Br J Cancer 80: 1306–1311
Cox JT, Lorincz AT and Schiffman MH (1995) Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 172: 946–954
Cuzick J, Terry G and Ho L (1994) Human papillomavirus DNA in cervical smears as a predictor of high-grade cervical intraepithelial neoplasia. Br J Cancer 69: 167–171
Cuzick J, Szarewski A and Terry G (1995) Human papillomavirus testing in primary cervical screening. Lancet 345: 1533–1536
Cuzick J, Beverley E and Ho L (1999) HPV testing in primary screening of older women. Br J Cancer 81: 554–558
Cuzick J and Sasieni P (2000) A systematic review of the role of human papillomavirus (HPV) testing within a cervical screening programme: summary and conclusions. Br J Cancer 83: 561–565
Franco EL, Villa LL and Sobrinho JP (1999) Epidemiology of acquisition and clearance of cervical human papillomavirus infection in wommen from a high-risk area for cervical cancer. J Infect Dis 180: 1415–1423
Gaarenstroom KN, Melkert P and Walboomers JMM (1994) Human papillomavirus DNA geneotypes: prognostic factors for progression of cervical intraepithelial neoplasia. Int J Gynecol Cancer 4: 73–78
Gustafson L and Adami HO (1989) Natural history of cervical neoplasia: consistent results obtained by an identification technique. Br J Cancer 60: 132–141
Herrero R, Hildisheim A and Bratti C (2000) Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 92: 464–474
Ho GY, Burk RD and Klein s (1995) Persistent genital human papillomavirus infection as a risk factor for persistent cervial dysplasia. J Natl Cancer Inst 187: 1365–1371
Ho GYF, Bierman R and Beardsley L (1998) Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338: 423–428
Kaufman RH and Adam E (1999) Is human papillomavirus testing of value in clinical practice?. Am J Obstet Gynecol 180: 1049–1053
Koutsky LA, Holmes KK and Critchlow CW (1992) a cohort study of the risk of cervial intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N engl J Med 327: 1272–1278
Kuhn L, Denny L and Pollack A (2000) Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst 92: 818–825
Liaw KL, Khildesheim A and Burk RD (2001) A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 183: 8–15
Lorincz AT (1996) Hybrid capture method for detection of human papillomavirus DNA in clinical specimens. Papillomavirus Rep 7: 1–5
Lorincz AT, Reid R and Jenson AB (1992) Human papillomavirus infection of the cervix: relative risk association of 15 common anogenital types. Obstet Gynecol 79: 328–337
Manos MM, Kinney WK and Hurley LB (1999) Identifying women with cervical neoplasia using human papillomavirus testing for equivocal Papanicolaou results. JAMA 281: 1605–1610
Meijer CJLM, Helmerhorst TJM and Rozendaal L (1998) HPV typing and testing in gynaecological pathology; has the time come?. Histopathology 33: 83–86
Papillo JL, Zarka MA and St-John TL (1998) Evaluation of the ThinPrep Pap test in clinical practice. A seven-month 16,314-case experience in Northern Vermont. Acta Cytologica 42: 203–208
Peyton CL, Schiffman MH and Lorincz AT (1998) Comparison of PCR and Hybrid Capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol 36: 3248–3254
Ratnam S, Franco EL and Ferenczy A (2000) Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiol Biomarkers Prev 9: 945–951
Remmink AJ, Walboomers JMM and Helmerhoorst TJM (1995) The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer 61: 306–311
Riethmuller D, Gay C and Bertrand X (1999) Genital human papillomavirus infection among women recruited for routine cervical cancer screening or for colposcopy determined by Hybrid capture II and Polymerase Chain Reaction. Diagn Mol Pathol 8: 157–164
Rozendaal L, Walboomers JMM and Van Der Linden JC (1996) PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears. Int J Cancer 68: 766–769
Schneider A, Zahm DM and Kirchmayr R (1996) Screening for cervical intraepithelial neoplasia grade 2/3. Am J Obstet. Gynecol 174: 1534–1541
Schiffman M, Herrero R and Hildisheim A (2000) HPV DNA testing in cervical cancer screening. Results from women in a high-risk province of Costa-Rica. JAMA 283: 87–93
Sherman ME, Mendoza M and Lee KR (1998) Performance of liquid-based, thin layer cervical cytology: correlation with reference diagnoses and human papillomavirus testing. Mod Pathol 11: 837–843
Solomon D, Schiffman M and Tarone R (2001) Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst 93: 293–299
Stoler M (2000) Advances in cervical screening technology. Mod Pathol 13: 275–284
The Atypical Squamous Cells of Undertermined Significance/Low Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group (2000) Human Papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst 92: 397–402
Vernon SD, Unger ER and Williams D (2000) Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture. J Clin Microbiol 38: 651–655
Walboomers JMM, Jacobs MV and Manos MM (1999) Human Papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12–19
Weintraub J and Morabia A (2000) Efficacy of a liquid-based thin layer method for cervical cancer screening in a population with low incidence of cervical cancer. Diagn Cytopathol 22: 52–59
Wright TC Jr, Lorincz AT and Ferris DG (1998) Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears. Am J Obstet Gynecol 178: 962–966
Ylitalo N, Sorensen P and Josepfsson AM (2000) Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested-case control study. Lancet 355: 2194–2198
Zur Hausen H (1994) Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 186: 131–156
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Clavel, C., Masure, M., Bory, JP. et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer 84, 1616–1623 (2001). https://doi.org/10.1054/bjoc.2001.1845
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.1845
Keywords
This article is cited by
-
Carcinogenesis and management of human papillomavirus-associated cervical cancer
International Journal of Clinical Oncology (2023)
-
High Prevalence of Cervical High-Risk Human Papillomavirus Harboring Atypical Genotypes in Human Immunodeficiency Virus -Infected and -Uninfected First-Generation Adult Immigrant Women Originating from Sub-Saharan Africa and Living in France
Journal of Immigrant and Minority Health (2021)
-
The advantages of incorporating liquid-based cytology (TACAS™) in mass screening for cervical cancer
Human Cell (2016)
-
A rapid and sensitive detection of HPV by combined assay of PCR and fluorescence DNA chip
BioChip Journal (2014)
-
Counseling the Patient with Potentially HPV-Related Newly Diagnosed Head and Neck Cancer
Current Oncology Reports (2014)